Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000481122 | SCV000568742 | pathogenic | not provided | 2023-05-11 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 36816037, 28488383, 12721955) |
Labcorp Genetics |
RCV001246978 | SCV001420373 | pathogenic | Aniridia 1; Irido-corneo-trabecular dysgenesis | 2019-11-15 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in PAX6 are known to be pathogenic (PMID: 12634864). This variant has been observed in individual(s) with aniridia or optic nerve hypoplasia (PMID: 28488383, 12721955). ClinVar contains an entry for this variant (Variation ID: 3476). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gln205*) in the PAX6 gene. It is expected to result in an absent or disrupted protein product. |
OMIM | RCV000003644 | SCV000023807 | pathogenic | Isolated optic nerve hypoplasia | 2003-06-01 | no assertion criteria provided | literature only |